Akkermansia muciniphila : a potential candidate for ameliorating metabolic diseases
Metabolic diseases are comprehensive disease based on obesity. Numerous cumulative studies have shown a certain correlation between the fluctuating abundance of and the occurrence of metabolic diseases. , a potential probiotic candidate colonized in the human intestinal mucus layer, and its derivati...
Saved in:
Published in | Frontiers in immunology Vol. 15; p. 1370658 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
20.03.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Metabolic diseases are comprehensive disease based on obesity. Numerous cumulative studies have shown a certain correlation between the fluctuating abundance of
and the occurrence of metabolic diseases.
, a potential probiotic candidate colonized in the human intestinal mucus layer, and its derivatives have various physiological functions, including treating metabolic disorders and maintaining human health. This review systematically explicates the abundance change rules of
in metabolic diseases. It also details the high efficacy and specific molecules mechanism of
and its derivatives in treating obesity, type 2 diabetes mellitus, cardiovascular disease, and non-alcoholic fatty liver disease. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 Edited by: Subash Babu, International Centers for Excellence in Research (ICER), India Suganthi Balasubramanian, International Centers for Excellence in Research (ICER), India Reviewed by: Anuradha Rajamanickam, International Centers for Excellence in Research (ICER), India |
ISSN: | 1664-3224 1664-3224 |
DOI: | 10.3389/fimmu.2024.1370658 |